A post-hoc analysis of the comparative efficacy of canagliflozin and glimepiride in the attainment of type 2 diabetes-related quality measures

BACKGROUND: The randomized, double-blind CANTATA-SU (CANagliflozin Treatment And Trial Analysis Sulfonyl Urea) clinical trial compared the use of canagliflozin (100 mg or 300 mg) and maximally tolerated glimepiride (6–8 mg) over 104 weeks as add-on therapy for patients with type 2 diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Charmi A., Bailey, Robert A., Vijapurkar, Ujjwala, Meininger, Gary, Blonde, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974722/
https://www.ncbi.nlm.nih.gov/pubmed/27495291
http://dx.doi.org/10.1186/s12913-016-1607-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974722/
https://www.ncbi.nlm.nih.gov/pubmed/27495291
http://dx.doi.org/10.1186/s12913-016-1607-z

Ejemplares similares